Vincent B Luscombe

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Systemic Sclerosis

Structure Activity Relationship

Top Venues

Journal of medicinal chemistry

British journal of pharmacology

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent B Luscombe, Pinqi Wang, Angela J Russell, David R Greaves
Biased agonists of GPR84 and insights into biological control. British journal of pharmacology 181 (10) (2024)
Rory A Capstick, Sean R Bollinger, Julie L Engers, Madeline F Long, Sichen Chang, Vincent B Luscombe, Alice L Rodriguez, Colleen M Niswender, Thomas M Bridges, Olivier Boutaud, P Jeffrey Conn, Darren W Engers, Dennis C Liotta, Kayla J Temple
Discovery of VU6008677: A Structurally Distinct Tricyclic M 4 Positive Allosteric Modulator with Improved CYP450 Profile. ACS medicinal chemistry letters 15 (8) (2024)
Vincent B Luscombe, Pinqi Wang, Angela J Russell, David R Greaves
Biased agonists of GPR84 and insights into biological control. British journal of pharmacology 181 (10) (2024)
Rory A Capstick, Sean R Bollinger, Julie L Engers, Madeline F Long, Sichen Chang, Vincent B Luscombe, Alice L Rodriguez, Colleen M Niswender, Thomas M Bridges, Olivier Boutaud, P Jeffrey Conn, Darren W Engers, Dennis C Liotta, Kayla J Temple
Discovery of VU6008677: A Structurally Distinct Tricyclic M 4 Positive Allosteric Modulator with Improved CYP450 Profile. ACS medicinal chemistry letters 15 (8) (2024)
Rory A Capstick, Sean R Bollinger, Julie L Engers, Madeline F Long, Sichen Chang, Vincent B Luscombe, Alice L Rodriguez, Colleen M Niswender, Thomas M Bridges, Olivier Boutaud, P Jeffrey Conn, Darren W Engers, Dennis C Liotta, Kayla J Temple
Discovery of VU6008677: A Structurally Distinct Tricyclic M 4 Positive Allosteric Modulator with Improved CYP450 Profile. ACS medicinal chemistry letters 15 (8) (2024)
Pinqi Wang, Arun Raja, Vincent B Luscombe, Carole J R Bataille, Daniel Lucy, Vanessa V Rogga, David R Greaves, Angela J Russell
Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists. Journal of medicinal chemistry 67 (1) (2023)
Pinqi Wang, Arun Raja, Vincent B Luscombe, Carole J R Bataille, Daniel Lucy, Vanessa V Rogga, David R Greaves, Angela J Russell
Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists. Journal of medicinal chemistry (2023)
Pinqi Wang, Arun Raja, Vincent B Luscombe, Carole J R Bataille, Daniel Lucy, Vanessa V Rogga, David R Greaves, Angela J Russell
Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists. Journal of medicinal chemistry 67 (1) (2023)
Pinqi Wang, Arun Raja, Vincent B Luscombe, Carole J R Bataille, Daniel Lucy, Vanessa V Rogga, David R Greaves, Angela J Russell
Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists. Journal of medicinal chemistry 67 (1) (2023)
Vincent B Luscombe, Pinqi Wang, Angela J Russell, David R Greaves
Biased agonists of GPR84 and insights into biological control. British journal of pharmacology (2023)
Pinqi Wang, Arun Raja, Vincent B Luscombe, Carole J R Bataille, Daniel Lucy, Vanessa V Rogga, David R Greaves, Angela J Russell
Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists. Journal of medicinal chemistry 67 (1) (2023)
Vincent B Luscombe, Pinqi Wang, Angela J Russell, David R Greaves
Biased agonists of GPR84 and insights into biological control. British journal of pharmacology (2023)
Pinqi Wang, Arun Raja, Vincent B Luscombe, Carole J R Bataille, Daniel Lucy, Vanessa V Rogga, David R Greaves, Angela J Russell
Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists. Journal of medicinal chemistry 67 (1) (2023)